web analytics
25 C
Munich
Thursday, August 11, 2022

The Parabolic Rise of Vystar Corp. (OTC: VYST)

Vystar Corp. (OTC: VYST) is making a powerful move up the charts marked by heavy accumulation and a massive surge of volume. VYST has runner in its blood with a long history of big moves making a specular run in early 2019 from triple zeroes to over $0.15 highs. Currently racing up the charts VYST is in full beast mode. Microcapdaily has been covering VYST since it was well below $0.01.

VYST has been getting noticed for its Rx3000 ultraviolet (UV)-light air purification system designed specifically for hospitals which utilizes ultraviolet-C (UV-C) germicidal irradiation (UVGI) to inactivate 99.97% of airborne viruses, bacteria and other pathogens on first pass. The Company also recently contracted with a manufacturer in Thailand for the production of ultra-low protein Vytex natural rubber latex disposable gloves for workers and consumers to help prevent the spread of coronavirus via hand contact.

Vystar Corp. (OTC: VYST) is a holding company for eco-friendly solutions for complex environmental challenges and the exclusive creator of Vytex Natural Rubber Latex (NRL), a multi-patented, all-natural, raw material that contains significantly reduced levels of the proteins found in natural rubber latex and can be used in over 40,000 products, and the owner of RxAir UV light air purification products. Vytex NRL is a 100% renewable resource, environmentally safe, “green” and fully biodegradable. Vystar is working with manufacturers across a broad range of consumer and medical products bringing Vytex NRL to market in adhesives, gloves, balloons, condoms, other medical devices and natural rubber latex foam mattresses, toppers, and pillows. Operating out of Worcester, MA, Vystar did $13.7 million in sales in 2019.

RxAir promotes a healthy lifestyle through the use of its innovative patented, ViraTech air purification technology, thereby improving the quality of life of each and every customer. Independently tested by EPA- and FDA-certified laboratories, the RxAir has been proven to destroy greater than 99% of bacteria and viruses and reduce concentrations of odors and VOCs. The RxAir uses high-intensity germicidal UV lamps that destroy bacteria and viruses instead of just trapping them, setting it apart from ordinary air filtration units. RxAir® and ViraTech® are registered trademarks of Vystar Corp.

To Find out the inside Scoop on VYST Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

VYST

VYST recently reported its Rx3000 is used in hundreds of hospitals and healthcare facilities. With an MSRP of $8,000 per unit to service a 1,500 – 3,000 sq. ft. area, Rx3000 is very cost effective. Vystar acquired 100% of the assets and patented intellectual property related to the Rx3000, RxAir™ for residential and small business use, custom filtration and other UV light air purification technologies from UV Flu Technologies (OTCBB: UVFT) in 2018. Vystar also acquired all of the equipment necessary to make the custom filters used in the Rx3000. These large multi-stage filters retail for approximately $800 and last up to 1 year, depending on use.

On July 30 VYST announced it) has contracted with a manufacturer in Thailand for the production of ultra-low protein Vytex natural rubber latex disposable gloves for workers and consumers to help prevent the spread of coronavirus via hand contact. Vytex disposable gloves offer superior tactile sensitivity, liquid barrier protection, puncture and tear resistance and flexibility — all with virtually no risk of developing or experiencing latex allergies from extended contact. They are expected to be available for online purchase in September 2020. Thanks to Vystar’s patented latex deproteinization process, disposable gloves made of Vytex latex are far superior to synthetic latex, nitrile, neoprene, and even traditional latex gloves as has been published in peer-reviewed industry journal articles.

CEO Steve Rotman stated:“By removing 99.85% of all the proteins and non-rubber components that cause allergies, the resulting Vytex latex is ultra-pure and creates a stronger molecular bond which enables production of a 50% stronger, yet 50% thinner glove than competitors. In addition to helping prevent spread of infectious viruses such as Coronavirus and influenza to surfaces, essential workers in food service, and jobs requiring hand contact with other people, chemicals, delicate or fine parts, and materials will appreciate the improved tactile sensitivity and flexibility, as well as the extra protection from leaks, punctures and tears.”

We have a Monster Pick Coming. Subscribe Right Now!

Currently heating up and running up the charts Vystar had a memorable 2019 reporting 13,685,872 in revenues according to its most recent 10k. VYST is on the move as its newest and most exciting division RxAir gains traction. RxAir patented, ViraTech air purification technology has been proven to destroy greater than 99% of bacteria and viruses and reduce concentrations of odors and VOCs. VYST Rx3000 is FDA cleared as a Class II Medical Device and was designed by biomedical engineers for use in hospitals and healthcare facilities. Rx3000 utilizes ultraviolet-C (UV-C) germicidal irradiation (UVGI) to inactivate 99.97% of airborne viruses, bacteria and other pathogens on first pass. According to VYST press release Rx3000 is used in hundreds of hospitals and healthcare facilities. The Company also recently contracted with a manufacturer in Thailand for the production of ultra-low protein Vytex natural rubber latex disposable gloves for workers and consumers to help prevent the spread of coronavirus via hand contact. Microcapdaily has been covering VYST since it was well below $0.01. We will be updating on VYST when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with VYST.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in VYST either long or short and we have not been compensated for this article.

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.